Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general ...

Treatment for millions of people with type 2 diabetes should be more personalised, with greater access to newer medicines, ...

The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, ...

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

In recent years, weight loss medications have gained significant attention, particularly as alternatives to established drugs like Ozempic and other GLP-1 receptor agonists. However, new research has ...

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to ...

Ozempic Vulva is a nickname some women are using to describe changes they have noticed in their genital area after taking ...

Viking Therapeutics (VKTX) stock drops even as a mid-stage trial for its oral weight loss drug VK2735 succeeds. Novo (NVO) ...